Credit Suisse’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Credit Suisse’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-134,179	Closed	-$1.09M	–	4529
2013 Q2	$1.09M	Buy	+134,179	New	+$991K	﹤0.01%	2725

Other funds holding TSRX

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Credit Suisse's TSRX Position: Q3 2013 in Review

Credit Suisse sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 134,179 shares — an estimated $1.09M sold.

Credit Suisse first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $1.09M in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

Credit Suisse reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
Credit Suisse sold 134,179 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $1.09M.
Credit Suisse first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
Credit Suisse's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $1.09M in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Credit Suisse's 13F filing for Q3 2013, filed 13 Nov 2013.